healthNewsغير مصنف

Galapagos bowel drug fails in research trial

BRUSSELS (Reuters) – Belgian biotech group Galapagos said its experimental drug to treat bowel disease ulcerative colitis had failed to prove its efficacy in a medical trial and it would discontinue the program for that disease.

اظهر المزيد

مقالات ذات صلة

زر الذهاب إلى الأعلى